Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLLS Cellectis S.A.

盘前交易 02-09 09:24:42 EST

3.57

+0.07

+2.00%

盘前3.72

+0.15+4.20%

08:00 EST

最高3.66	最低3.49	成交量1.88万
今开3.66	昨收3.50	日振幅4.86%
总市值3.57亿	流通市值2.39亿	总股本1.00亿
成交额6.72万	换手率0.03%	流通股本6,691万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis S.A.","latestPrice":3.57,"timestamp":1770411600000,"preClose":3.5,"halted":0,"volume":18796,"hourTrading":{"tag":"盘前","latestPrice":3.72,"preClose":3.57,"latestTime":"08:00 EST","volume":97,"amount":360.67519699999997,"timestamp":1770642007397,"change":0.15,"changeRate":0.042017,"amplitude":0},"delay":0,"changeRate":0.019999999999999955,"floatShares":66909900,"shares":100000000,"eps":-0.353485,"marketStatus":"盘前交易","change":0.07,"latestTime":"02-09 09:24:42 EST","open":3.66,"high":3.66,"low":3.49,"amount":67198.69796199999,"amplitude":0.048571,"askPrice":3.93,"askSize":12000,"bidPrice":3.76,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.353485,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770647400000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1427256000000,"exchange":"NASDAQ","adjPreClose":3.57,"preHourTrading":{"tag":"盘前","latestPrice":3.72,"preClose":3.57,"latestTime":"08:00 EST","volume":97,"amount":360.67519699999997,"timestamp":1770642007397,"change":0.15,"changeRate":0.042017,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.57,"latestTime":"16:32 EST","volume":376,"amount":1278.74,"timestamp":1770413577467,"change":-0.17,"changeRate":-0.047619,"amplitude":0.047619},"volumeRatio":0.3336173244595513,"impliedVol":1.4524,"impliedVolPercentile":0.652},"requestUrl":"/m/hq/s/CLLS","defaultTab":"news","newsList":[{"id":"2607027462","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607027462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607027462?lang=zh_cn&edition=full","pubTime":"2026-01-31 02:31","pubTimestamp":1769797880,"startTime":"0","endTime":"0","summary":"北京时间2026年01月31日02时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速下挫5.01%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.81%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞产品候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131023120a46a3a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260131023120a46a3a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2607205067","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.17%报3.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607205067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607205067?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:25","pubTimestamp":1769700304,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日23时25分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速下挫5.17%。截至发稿，该股报3.85美元/股，成交量1.8123万股，换手率0.02%，振幅3.45%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923250497a4058f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012923250497a4058f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2588082140","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588082140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588082140?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:31","pubTimestamp":1764599461,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.33%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.44%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞产品候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012231019524da70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012231019524da70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2583268533","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.04%报3.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583268533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583268533?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:44","pubTimestamp":1763135058,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时44分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅拉升5.04%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.40%。消息层面，截至23时44分，《富国集团维持Cellectis持有评级，维持目标价4美元》资讯为影响Cellectis Ads Each Repr 1 Ord Spon的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2582399964","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582399964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582399964?lang=zh_cn&edition=full","pubTime":"2025-11-12 01:58","pubTimestamp":1762883927,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日01时58分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速上涨5.07%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.52%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞产品候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112015847a49a608c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112015847a49a608c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2574127963","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘大幅跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574127963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574127963?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:30","pubTimestamp":1760020257,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日22时30分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速下跌5.54%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.17%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞产品候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100922305897254ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100922305897254ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":1},{"id":"2566607539","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘急速拉升7.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566607539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566607539?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:56","pubTimestamp":1757512594,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时56分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速拉升7.37%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.43%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞产品候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910215635a71bf86b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910215635a71bf86b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2558684831","title":"Cellectis Ads Each Repr 1 Ord Spon2025财年第二财季实现净利润-24.04百万美元，同比增加4.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558684831?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:00","pubTimestamp":1754841632,"startTime":"0","endTime":"0","summary":"8月11日，Cellectis Ads Each Repr 1 Ord Spon公布财报，公告显示公司2025财年第二财季净利润为-24.04百万美元，同比增加4.87%；其中营业收入为16.94百万美元，同比增加110.17%，每股基本收益为-0.24美元。从资产负债表来看，Cellectis Ads Each Repr 1 Ord Spon总负债2.57亿美元，其中短期债务25.71百万美元，资产负债比为1.38，流动比率为1.39。机构评级：截至2025年8月11日，当前有7家机构对Cellectis Ads Each Repr 1 Ord Spon目标价做出预测，其中目标均价为5.50美元，其中最低目标价为3.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000048a48055e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000048a48055e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS"],"gpt_icon":0},{"id":"2516634916","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨6.31%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634916?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012356,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速上涨6.31%。截至发稿，该股报1.37美元/股，成交量6275股，换手率0.01%，振幅0.02%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.44%、27.60%、23.01%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223236abe63383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223236abe63383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2516031173","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速跳水5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516031173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516031173?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:13","pubTimestamp":1740769991,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时13分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速下跌5.26%。截至发稿，该股报1.26美元/股，成交量11.4681万股，换手率0.11%，振幅4.51%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031311abe12976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031311abe12976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2514043332","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514043332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:24","pubTimestamp":1740687840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时24分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速跳水5.00%。截至发稿，该股报1.33美元/股，成交量20.9548万股，换手率0.21%，振幅5.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804240098955083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804240098955083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2514101306","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.87%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514101306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514101306?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:21","pubTimestamp":1740496901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时21分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅下挫5.87%。截至发稿，该股报1.41美元/股，成交量2.9474万股，换手率0.03%，振幅7.34%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.80%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523214198925807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523214198925807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2511961106","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511961106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511961106?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543482,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速上涨5.24%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.18%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223122a24600b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223122a24600b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CLLS","VRPX"],"gpt_icon":0},{"id":"2511173525","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.08%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511173525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511173525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:30","pubTimestamp":1739457049,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时30分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅上涨5.08%。截至发稿，该股报1.55美元/股，成交量784股，换手率0.00%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.00%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223049abcdb1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223049abcdb1c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2510863474","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速拉升5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863474?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739197999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速拉升5.23%。截至发稿，该股报1.61美元/股，成交量1856股，换手率0.00%，振幅2.61%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.32%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223319a240a274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223319a240a274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","CLLS"],"gpt_icon":0},{"id":"2509277199","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509277199?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:53","pubTimestamp":1738853580,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时53分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速上涨5.62%。截至发稿，该股报1.69美元/股，成交量641股，换手率0.00%，振幅2.06%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.36%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225300961a1cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225300961a1cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2509461259","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509461259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509461259?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:50","pubTimestamp":1738687853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时50分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速拉升5.13%。截至发稿，该股报1.64美元/股，成交量1.9512万股，换手率0.02%，振幅2.56%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205005053abc24298&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205005053abc24298&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2508149514","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149514?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:37","pubTimestamp":1738593467,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时37分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.59%。截至发稿，该股报1.52美元/股，成交量7820股，换手率0.01%，振幅1.50%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.40%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322374798797033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322374798797033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2506511035","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 大幅拉升7.14%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506511035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506511035?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074684,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速上涨7.14%。截至发稿，该股报1.65美元/股，成交量3158股，换手率0.00%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.01%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822312498756b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822312498756b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2506307574","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506307574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506307574?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:50","pubTimestamp":1737996616,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时50分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.39%。截至发稿，该股报1.58美元/股，成交量3.0765万股，换手率0.03%，振幅2.99%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128005016a2318766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128005016a2318766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":-0.058},{"period":"1month","weight":-0.2154},{"period":"3month","weight":0.1191},{"period":"6month","weight":0.3731},{"period":"1year","weight":1.2453},{"period":"ytd","weight":-0.2624}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectis S.A.于2000年1月4日成立。该公司是一家处于临床阶段的生物技术公司，利用他们的核心专有技术开发基于基因编辑的产品，拥有一系列同种异体嵌合抗原受体T细胞，即免疫肿瘤学领域的候选产品和基因编辑造血干细胞和祖细胞，即HSPC，其他治疗适应症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.025762},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.077413},{"month":3,"riseRate":0.6,"avgChangeRate":-0.034139},{"month":4,"riseRate":0.363636,"avgChangeRate":0.028145},{"month":5,"riseRate":0.636364,"avgChangeRate":0.053843},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.075756},{"month":7,"riseRate":0.363636,"avgChangeRate":0.040955},{"month":8,"riseRate":0.727273,"avgChangeRate":0.056431},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.108663},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.048106},{"month":11,"riseRate":0.545455,"avgChangeRate":0.268959},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.008306}],"exchange":"NASDAQ","name":"Cellectis S.A.","nameEN":"Cellectis SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectis S.A.,CLLS,Cellectis S.A.股票,Cellectis S.A.股票老虎,Cellectis S.A.股票老虎国际,Cellectis S.A.行情,Cellectis S.A.股票行情,Cellectis S.A.股价,Cellectis S.A.股市,Cellectis S.A.股票价格,Cellectis S.A.股票交易,Cellectis S.A.股票购买,Cellectis S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}